307
ך
ĂđÿîĂĒîą
ĀćÖÿćöćøëìĞ
ćÖćøýċ
Öþćüĉ
ÝĆ
÷ĔîøĎ
ðĒïïÖćøýċ
Öþćĕðך
ćÜĀîš
ćǰ(Prospective study) ĕéš
ÝąìĞ
ćĔĀš
ĕéš
ך
ĂöĎ
úìĊę
ëĎ
Öêš
ĂÜǰ
Ùøïëš
üîêćöìĊę
üćÜĒñîĕüš
ǰĒúąÿćöćøëúéðŦ
ÝÝĆ
÷ìĊę
đðŨ
îêĆ
üÖüîêŠ
ćÜėĔîÖćøüĉ
ÝĆ
÷ĕéš
ǰîĂÖÝćÖîĊĚ
÷Ć
ÜìĞ
ćĔĀš
Üćîüĉ
ÝĆ
÷öĊ
ÙüćöîŠ
ćđßČę
ĂëČ
Ă
öćÖ×ċĚ
îǰĀøČ
ĂĂćÝđóĉę
öÖćøêĉ
éêćöÙîĕך
ĀúĆ
ÜÝćÖðøĆ
ïóùêĉ
ÖøøöĔîÖćøéĎ
ĒúêîđĂÜēé÷ÖćøüĆ
éÙŠ
ćǰCAVI đðøĊ
÷ïđìĊ
÷ïÖŠ
ĂîĒúąĀúĆ
Ü
ÖćøðøĆ
ïđðúĊę
÷îóùêĉ
ÖøøöĀøČ
ĂÖćøøĆ
ÖþćìĊę
ĔĀš
đóĉę
öđêĉ
öĕéš
ĂĊ
Öéš
ü÷
ÙĞ
ć×ĂïÙč
è
Üćîüĉ
ÝĆ
÷îĊĚ
ĕéš
øĆ
ïÖćøÿîĆ
ïÿîč
îÝćÖǰøó Öøč
ÜđìóǰĒúąöĀćüĉ
ì÷ćúĆ
÷ĒöŠ
ôŜ
ćĀúüÜǰñĎš
üĉ
ÝĆ
÷×Ă×ĂïÙč
èǰøó Öøč
ÜđìóĀćéĔĀâŠ
ÿĞ
ćĀøĆ
ïך
ĂöĎ
úÖćøìĞ
ćüĉ
ÝĆ
÷ĔîÙøĆĚ
ÜîĊĚ
ǰēé÷đÞóćąĂ÷Š
ćÜ÷ĉę
Üǰîó Ăøč
èǰÖĉ
ÝöĀćêøąÖĎ
úǰñĂ øó Öøč
ÜđìóĀćéĔĀâŠ
ǰìĊę
ĔĀš
Öćøߊ
ü÷đĀúČ
Ă
ÿîĆ
ïÿîč
îĔĀš
Üćîüĉ
ÝĆ
÷ÿĞ
ćđøĘ
ÝđðŨ
îĂ÷Š
ćÜéĊ
đĂÖÿćøĂš
ćÜĂĉ
Ü
[1] Alberti KG, Zimmet P, Shaw J; (2005). IDF Epidemiology Task Force Consensus Group. The metabolic
syndrome a new worldwide definition.
Lancet
. 366:1059-62.
[2] Alberti KG, Zimmet P, Shaw J. (2006). Metabolic syndrome-a new world-wide definition. A Consensus
Statement from the International Diabetes Federation.
Diabet Med
ǰ
23(5):469-80.
[3] Stern M, Williams K, Gonzalez-Villalpando C et al. (2004). Does the metabolic syndrome improve
identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?
Diabetes
Care.
27(11):2676-81.
[4]
ǰǰ
Diabetes Atlas
, second edition, (2003). International Diabetes Federation
[5] UKPDS Group. (1996). UK Prospective Diabetes Study 17: A nine-year update of a randomized,
controlled trial on the effect of improved metabolic control on complications in non-insulin-
dependent diabetes mellitus.
Ann Intern Med
. 124:136–45.
[6] Sattar N, Gaw A, Scherbakova O. (2003). Metabolic syndrome with and without c-reactive protein as a
predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention
Study.
Circulation.
108:414-9.
[7] Golden SH, Folsom AR, Coresh J et al. (2002). Risk factor grouping related to insulin resistance and their
synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study.
Diabetes.
51:3069-76.
[8] World Health Organization. (1994). Technical Report Series no. 844.
Prevention of diabetes mellitus
.
WHO, Geneva.
[9] Williams R. (2004
).
Presentation at the International Diabetes Federation symposium “The Metabolic
Syndrome”, The medical and economic case for prevention of type 2 diabetes and cardiovascular
disease.
Implications for health systems II
. 1st July, 2004. Brussels.
